Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Cua

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Medecine Et Maladies Infectieuses|August 19, 2008
[Computerized management of a medical department, disease-related group management, clinical research and evaluations]P-M Roger, R Farhad, S Leroux, et al.
Medecine Et Maladies Infectieuses|January 22, 2011
[Duration of antibiotic therapy in bone infection and biological or radiological data]P M Roger, V Lesbats, E Cua, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 3, 2014
Community-acquired pneumonia: impact of empirical antibiotic therapy without respiratory fluoroquinolones nor third-generation cephalosporinsJ Pradelli, K Risso, F G de Salvador, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 24, 2013
Antibiotics-related adverse events in the infectious diseases department of a French teaching hospital: a prospective studyJ Courjon, C Pulcini, E Cua, et al.
Medecine Et Maladies Infectieuses|October 10, 2012
Cutaneous infections, good use of antibiotics and diagnostic accuracyP M Roger, K Risso, F de Salvador, et al.
La Revue De Medecine Interne|June 18, 2002
[Necrobiotic xanthogranuloma , a cutaneous disorder associated with monoclonal gammopathy]S Roth, E Delmont, F Heinrich, et al.
Medecine Et Maladies Infectieuses|May 1, 2009
[Usefulness of C-reactive protein in the therapeutic follow-up of infected patients]P-M Roger, S Hung, F de Salvador, et al.
HIV Medicine|November 5, 2005
Triple nucleoside reverse transcriptase inhibitor- vs. nonnucleoside reverse transcriptase inhibitor-containing regimens as first-line therapy: efficacy and durability in a prospective cohort of French HIV-infected patientsL Cuzin, P Pugliese, F Bugnon, et al.
HIV Clinical Trials|April 3, 2003
Variable virological outcomes according to the center providing antiretroviral therapy within the PharmAdapt clinical trialP Clevenbergh, M C Bozonnat, M Kirstetter, et al.
Medecine Et Maladies Infectieuses|February 2, 2010
[Evaluation of clinical practice, medical computerized database and improvement of antibiotic therapy for acute community-acquired pneumonia]P-M Roger, F De Salvador, M-H Schiano, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Medecine Et Maladies Infectieuses|August 19, 2008
[Computerized management of a medical department, disease-related group management, clinical research and evaluations]P-M Roger, R Farhad, S Leroux, et al.
Medecine Et Maladies Infectieuses|January 22, 2011
[Duration of antibiotic therapy in bone infection and biological or radiological data]P M Roger, V Lesbats, E Cua, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 3, 2014
Community-acquired pneumonia: impact of empirical antibiotic therapy without respiratory fluoroquinolones nor third-generation cephalosporinsJ Pradelli, K Risso, F G de Salvador, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 24, 2013
Antibiotics-related adverse events in the infectious diseases department of a French teaching hospital: a prospective studyJ Courjon, C Pulcini, E Cua, et al.
Medecine Et Maladies Infectieuses|October 10, 2012
Cutaneous infections, good use of antibiotics and diagnostic accuracyP M Roger, K Risso, F de Salvador, et al.
La Revue De Medecine Interne|June 18, 2002
[Necrobiotic xanthogranuloma , a cutaneous disorder associated with monoclonal gammopathy]S Roth, E Delmont, F Heinrich, et al.
Medecine Et Maladies Infectieuses|May 1, 2009
[Usefulness of C-reactive protein in the therapeutic follow-up of infected patients]P-M Roger, S Hung, F de Salvador, et al.
HIV Medicine|November 5, 2005
Triple nucleoside reverse transcriptase inhibitor- vs. nonnucleoside reverse transcriptase inhibitor-containing regimens as first-line therapy: efficacy and durability in a prospective cohort of French HIV-infected patientsL Cuzin, P Pugliese, F Bugnon, et al.
HIV Clinical Trials|April 3, 2003
Variable virological outcomes according to the center providing antiretroviral therapy within the PharmAdapt clinical trialP Clevenbergh, M C Bozonnat, M Kirstetter, et al.
Medecine Et Maladies Infectieuses|February 2, 2010
[Evaluation of clinical practice, medical computerized database and improvement of antibiotic therapy for acute community-acquired pneumonia]P-M Roger, F De Salvador, M-H Schiano, et al.
Pageof 4